226 participants
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-18
- Start Date:
- 2025-11-15
- Completion:
- 2027-06-01
Conditions
- Ovarian Clear Cell Carcinoma
Interventions
- DRUG
No Results Yet